ZOLL RESPICARDIA, INC. – Trademark Portfolio
Entity Type: 03
ZOLL RESPICARDIA, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 8 trademarks are registered and 1 is pending. Notable registered marks include REMEDE, REMEDE EL, RESPISTIM, REMEDE ELX, and RESPIGUIDE. The owner is based in MINNETONKA, MN.
12400 WHITEWATER DR
STE 150
MINNETONKA, MN 55343
Showing of trademarks Trademarks
Trademark Classifications
ZOLL RESPICARDIA, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ZOLL RESPICARDIA, INC. have?
ZOLL RESPICARDIA, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 2 abandoned, 2 cancelled.
What trademark classes does ZOLL RESPICARDIA, INC. file in?
ZOLL RESPICARDIA, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ZOLL RESPICARDIA, INC.'s most well-known trademarks?
ZOLL RESPICARDIA, INC.'s registered trademark portfolio includes well-known marks such as REMEDE, REMEDE EL, RESPISTIM, REMEDE ELX, and RESPIGUIDE. These are among 8 currently registered trademarks in the portfolio.
What is ZOLL RESPICARDIA, INC.'s trademark registration success rate?
ZOLL RESPICARDIA, INC. has a 67% trademark registration rate, with 8 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.